Evidence map›Paper›PMID 33116300›Full record

ReviewNature reviews. Microbiology2021

Coronavirus biology and replication: implications for SARS-CoV-2.

Philip V'kovski, Annika Kratzel, Silvio Steiner, Hanspeter Stalder, Volker Thiel

Abstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,954 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,954citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,954 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,894 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Philip V'kovskiInstitute of Virology and Immunology (IVI), Bern, Switzerland.ORCID http://orcid.org/0000-0002-8366-1220
Annika KratzelInstitute of Virology and Immunology (IVI), Bern, Switzerland.
Silvio SteinerInstitute of Virology and Immunology (IVI), Bern, Switzerland.
Hanspeter StalderInstitute of Virology and Immunology (IVI), Bern, Switzerland.ORCID http://orcid.org/0000-0003-0763-6469
Volker ThielInstitute of Virology and Immunology (IVI), Bern, Switzerland. volker.thiel@vetsuisse.unibe.ch.ORCID http://orcid.org/0000-0002-5783-0887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 pandemic and its unprecedented global societal and economic disruptive impact has marked the third zoonotic introduction of a highly pathogenic coronavirus into the human population. Although the previous coronavirus SARS-CoV and MERS-CoV epidemics raised awareness of the need for clinically available therapeutic or preventive interventions, to date, no treatments with proven efficacy are available. The development of effective intervention strategies relies on the knowledge of molecular and cellular mechanisms of coronavirus infections, which highlights the significance of studying virus-host interactions at the molecular level to identify targets for antiviral intervention and to elucidate critical viral and host determinants that are decisive for the development of severe disease. In this Review, we summarize the first discoveries that shape our current understanding of SARS-CoV-2 infection throughout the intracellular viral life cycle and relate that to our knowledge of coronavirus biology. The elucidation of similarities and differences between SARS-CoV-2 and other coronaviruses will support future preparedness and strategies to combat coronavirus infections.

Indexed as

AnimalsCOVID-19COVID-19 Drug TreatmentHost-Pathogen InteractionsHumansSARS-CoV-2Viral ProteinsVirus InternalizationVirus ReplicationViral Proteins

Identifiers

PMID33116300
PMCPMC7592455

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.